SARS-CoV-2 spike protein could be speeding up Alzheimer’s and other brain diseases, says new study

Swedish researchers find that SARS-CoV-2’s spike protein amyloids can accelerate the formation of harmful protein aggregates related to neurodegenerative diseases like Creutzfeldt-Jakob and Alzheimer’s. The study suggests a potential link between COVID-19 and increased cases of these brain disorders.

UMSOM wins $3.5 million BARDA contract to develop animals models for radiation research

University of Maryland School of Medicine Dean Mark T. Gladwin, MD, announced today that UMSOM faculty scientists have been selected as key contractors by the

February 27, 2024

A majority of pharma and biotech companies prohibit ChatGPT use, survey finds

Most pharma and biotech companies ban or restrict the use of ChatGPT by their employees, according to a recent survey. Half of pharma and biotech

April 18, 2024

IO360: Motixafortide shows Phase II efficacy in first-line pancreatic cancer – Pharmaceutical Technology

Share this article An illustration of the human body highlighting the pancreas. Image Credit: Magic mine Pancreatic ductal adenocarcinoma (PDAC), notorious for its resistance to

March 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.